Unknown

Dataset Information

0

The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer.


ABSTRACT: Metastatic prostate cancer is a heterogeneous disease entity. Men without prior androgen deprivation therapy exposure are termed metastatic castration sensitive prostate cancer (mCSPC). The goal of this article is to update the reader on the rapidly changing landscape of treatment for men with mCSPC. Along with the options available to the clinician for treatment of men with mCSPC, the care of these patients has evolved into a multi-disciplinary field with expanding roles for medical, urologic, and radiation oncologists.

SUBMITTER: Parker DC 

PROVIDER: S-EPMC7004830 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer.

Parker Daniel C DC   Cookson Michael S MS  

Investigative and clinical urology 20200116 Suppl 1


Metastatic prostate cancer is a heterogeneous disease entity. Men without prior androgen deprivation therapy exposure are termed metastatic castration sensitive prostate cancer (mCSPC). The goal of this article is to update the reader on the rapidly changing landscape of treatment for men with mCSPC. Along with the options available to the clinician for treatment of men with mCSPC, the care of these patients has evolved into a multi-disciplinary field with expanding roles for medical, urologic,  ...[more]

Similar Datasets

| S-EPMC3539272 | biostudies-literature
| S-EPMC10262980 | biostudies-literature
| S-EPMC3399094 | biostudies-literature
| S-EPMC8575582 | biostudies-literature
| S-EPMC3685202 | biostudies-literature
| S-EPMC6402766 | biostudies-literature
| S-EPMC6219496 | biostudies-literature
| S-EPMC4698193 | biostudies-literature
| S-EPMC9302741 | biostudies-literature
| S-EPMC7042830 | biostudies-literature